JULIE IELLIMO: Open Payments
NPI 1750440657 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 23 payments from 11 companies in 2025. Trend: 2023 $3,094 · 2024 $242 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 4 | $101 |
| ABBVIE INC. | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Amgen Inc. | 3 | $49 |
| LEO Pharma Inc. | 2 | $47 |
| UCB, Inc. | 2 | $44 |
| Galderma Laboratories, L.P. | 1 | $31 |
| Biofrontera Inc. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
Products named: DUPIXENT, SKYRIZI, SPEVIGO, Otezla, VTAMA, ADBRY, Bimzelx, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
